Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M010852200 on January 25, 2001

J. Biol. Chem., Vol. 276, Issue 17, 14124-14132, April 27, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/17/14124    most recent
M010852200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaitovich-Groisman, I.
Right arrow Articles by Alaoui-Jamali, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaitovich-Groisman, I.
Right arrow Articles by Alaoui-Jamali, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue*

Iris Jaitovich-GroismanDagger , Naciba BenlimameDagger , Betty L. Slagle§, Maite Hernandez PerezDagger , Lesley AlpertDagger , Daniel J. SongDagger , Nasser Fotouhi-ArdakaniDagger , Jacques GalipeauDagger , and Moulay A. Alaoui-JamaliDagger

From the Dagger  Lady Davis Institute of the Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine, Pharmacology and Therapeutics, Pathology, and Oncology, Faculty of Medicine, McGill University, Montreal H3T 1E2, Canada, and the § Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030

Human hepatitis B virus is a risk factor for the development of hepatocellular carcinoma. The hepatitis B virus x protein (HBx) has been shown to inactivate the p53 tumor suppressor protein and impair DNA repair, cell cycle, and apoptosis mechanisms. Herein we report that HBx represses two components of the transcription-repair factor TFIIH, XPB (p89), and XPD (p80), both in p53-proficient and p53-deficient liver cells. This inhibition is observed while HBx maintains its transactivation function. Expression of HBx in liver cells results in down-regulation of endogenous XPB and XPD mRNAs and proteins; this inhibition is not observed with other TFIIH subunits, XPA or PCNA. In liver tissue from HBx transgenics, XPB and XPD proteins are down-regulated in comparison to matched normal liver tissue. HBx has been shown to interact with Sp1 transcription factor and affects its DNA binding activity. Sp1 is essential for the basal promoter activity of XPB in liver cells and Drosophila SL2 cells. In the Sp1-deficient SL2 cells, HBx-induced XPB and XPD inhibition is Sp1-dependent. In summary, our results provide evidence that HBx represses the expression of key TFIIH proteins at least in part through Sp1 elements; this repression may impair TFIIH function in DNA repair mechanisms.


* This work was supported by the Cancer Research Society of Canada (to M. A. A.-J.) and National Institutes of Health Grant 54SS7 (to B. L. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Senior Scientist of the "Fond de Recherches en Santé du Québec" (FRSQ). To whom correspondence should be addressed: Lady Davis Institute for Medical Research, Rm. 523, 3755 Chemin Cote-Ste-catherine, Montreal (Quebec) H3T 1E2, Canada. Tel.: 514-340-8260 (ext. 3438); Fax: 514-340-7576; E-mail: malaou@po-box.mcgill.ca.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
N H Park, I H Song, and Y-H Chung
Chronic hepatitis B in hepatocarcinogenesis.
Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Alaoui-Jamali, D. J. Song, N. Benlimame, L. Yen, X. Deng, M. Hernandez-Perez, and T. Wang
Regulation of Multiple Tumor Microenvironment Markers by Overexpression of Single or Paired Combinations of ErbB Receptors
Cancer Res., July 1, 2003; 63(13): 3764 - 3774.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Yen, N. Benlimame, Z.-R. Nie, D. Xiao, T. Wang, A.-E. A. Moustafa, H. Esumi, J. Milanini, N. E. Hynes, G. Pages, et al.
Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers
Mol. Biol. Cell, November 1, 2002; 13(11): 4029 - 4044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement